substance p has been researched along with Uterine Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, TA; Báez, D; Bello, AR; Candenas, L; Dorta, I; González-Santana, A; Hernández, M; Marrero-Hernández, S; Pinto, FM | 1 |
| Cherwitz, DL; Savage, JE; Stanley, M; Wick, MR | 1 |
| Goetzl, EJ; Longo, DL; Schiogolev, SA; Urba, WJ | 1 |
3 other study(ies) available for substance p and Uterine Neoplasms
| Article | Year |
|---|---|
Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata.
Topics: Adult; Biomarkers, Tumor; Blotting, Western; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Leiomyoma; Middle Aged; Neurokinin A; Real-Time Polymerase Chain Reaction; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substance P; Tachykinins; Uterine Neoplasms | 2016 |
Concomitant neuropeptide-producing endometrial carcinomas and ileal carcinoid tumors.
Topics: Aged; Carcinoid Tumor; Female; Gastrins; Histocytochemistry; Humans; Ileal Neoplasms; Nerve Tissue Proteins; Substance P; Uterine Neoplasms | 1986 |
Appearance of neuropeptides in ascitic fluid after peritoneal therapy with interleukin-2 and lymphokine-activated killer cells for intraabdominal malignancy.
Topics: Ascitic Fluid; Calcitonin Gene-Related Peptide; Colonic Neoplasms; Female; Humans; Interleukin-2; Killer Cells, Natural; Neuropeptides; Ovarian Neoplasms; Recombinant Proteins; Substance P; Uterine Neoplasms | 1989 |